Innovating Works
BBDiag: Blood Biomarker based Diagnostic Tools for Early Stage Alzheimer s Disease UNIVERSITY OF PLYMOUTH tramitó un H2020: H2020-MSCA-ITN-2016 Alzheimer’s disease (AD) affects more than 7 million people in Europe and this figure is expected to double every 20 years. Despite intensiv...
2016-09-12 - 2021-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.